ClinicalTrials.gov
ClinicalTrials.gov Menu

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00040625
Recruitment Status : Approved for marketing
First Posted : July 4, 2002
Last Update Posted : March 15, 2007
Sponsor:
Information provided by:
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Approved for marketing
  Primary Completion Date : No date given
  Study Completion Date : No date given